Oncimmune logo

Oncimmune is a leading early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow cancer detection up to four years earlier than other methods and can be applied to a wide range of solid tumour types.

Oncimmune Ltd is headquartered in Nottingham, UK and testing is conducted in our CLIA-approved laboratory, based in Kansas City, USA.

Contact Oncimmune via their website

News archive

13/09/2018   Oncimmune USA LLC Appoints Marco Casarin as General Manager...more
24/05/2018   Oncimmune Study Shows Cost-Effectiveness of EarlyCDT®-Lung Test...more
14/05/2018   Oncimmune Launches EarlyCDT®-Liver Test in the US...more
20/04/2018   Oncimmune joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code